These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38339026)

  • 41. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets.
    Jiang Z; Wang Z; Wei X; Yu XF
    Front Immunol; 2022; 13():1059994. PubMed ID: 36618399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update.
    Garcia-Santibanez R; Burford M; Bucelli RC
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):93. PubMed ID: 30328519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders.
    Minj E; Yadav RK; Mehan S
    Curr Mol Med; 2021; 21(8):630-644. PubMed ID: 33430731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senolytics: A Novel Strategy for Neuroprotection in ALS?
    Maximova A; Werry EL; Kassiou M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis.
    Müller HP; Agosta F; Gorges M; Kassubek R; Spinelli EG; Riva N; Ludolph AC; Filippi M; Kassubek J
    Neuroimage Clin; 2018; 20():1062-1069. PubMed ID: 30343251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2003; (4):CD003457. PubMed ID: 14583978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003457. PubMed ID: 18425887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Guo J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008554. PubMed ID: 21901724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study.
    Müller HP; Gorges M; Kassubek R; Dorst J; Ludolph AC; Kassubek J
    Neuroimage Clin; 2018; 18():762-769. PubMed ID: 29785360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Edaravone May Prevent Ferroptosis in ALS.
    Spasić S; Nikolić-Kokić A; Miletić S; Oreščanin-Dušić Z; Spasić MB; Blagojević D; Stević Z
    Curr Drug Targets; 2020; 21(8):776-780. PubMed ID: 32077821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
    J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
    Gurney ME
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis.
    Clark CM; Clark RM; Hoyle JA; Dickson TC
    J Neurochem; 2021 Feb; 156(3):273-289. PubMed ID: 32654149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings.
    Alam M; Yadav RK; Minj E; Tiwari A; Mehan S
    Curr Mol Pharmacol; 2021; 14(3):263-280. PubMed ID: 32342825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral Sclerosis.
    Zhu J; Shen L; Lin X; Hong Y; Feng Y
    Biomed Pharmacother; 2017 Dec; 96():854-864. PubMed ID: 29078263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.